Medical use of 5-benzylaminosalicylic acid derivative or its salt

Details for Australian Patent Application No. 2010211491 (hide)

Owner NEUROTECH PHARMACEUTICALS CO., LTD.

Inventors Gwag, Byoung-Joo; Son, Sun-Joo; Noh, Jae-Sung; Shin, Jin-Hee

Agent Collison & Co

Pub. Number AU-A-2010211491

PCT Pub. Number WO2010/090494

Priority 10-2009-0010068 09.02.09 KR; 10-2010-0011521 08.02.10 KR

Filing date 9 February 2010

Wipo publication date 12 August 2010

International Classifications

A61K 31/192 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

22 September 2011 PCT application entered the National Phase

  PCT publication WO2010/090494 Priority application(s): WO2010/090494

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010211580-Hydrazide compound and use of the same in pest control

2010211456-Antibacterial phage, phage peptides and methods of use thereof